Page title
Search SAMHSA Publications and Digital Products
Store Facets Summary
- Clear all filters
- Remove People with Substance Use or Abuse Problems as Audience
- Remove Prevention Professionals
- Remove Guidelines or Manual
- Remove Practitioner/Professional
- Remove Cocaine
- Remove Oxycodone
- Remove Pain Relievers
- Remove Dextromethorphan
- Remove Treatment
- Remove 12 Step Programs
- Remove Education
- Remove Family Treatment Approach
- Remove Motivational Interventions
Main page content
Displaying results 1 - 4 of 4
TIP 63: Medications for Opioid Use Disorder - Executive Summary
Published: August 2021
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
TIP 63: Medications for Opioid Use Disorder - Full Document
Published: July 2021
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Treatment of Stimulant Use Disorders
Published: June 2020
This guide supports health care providers, systems, and communities seeking to treat stimulant use disorders. It describes relevant research findings, examines best practices, identifies knowledge gaps and implementation challenges, and offers useful resources.
Matrix Intensive Outpatient Treatment for People With Stimulant Use Disorders: Client's Handbook
Published: October 2015
This guide contains patient materials for an intensive outpatient treatment course for stimulant misuse. It provides handouts to use in individual and conjoint sessions, and sessions on early recovery skills and relapse prevention.